Predicting Chemosensitivity to Gemcitabine and Cisplatin Based on Gene Polymorphisms and mRNA Expression in Non-Small-Cell Lung Cancer Cells

Authors:

Abstract
Aim: We used a panel of 17 non-small-cell lung cancer cell lines to investigate whether the presence of polymorphisms in the RRM1, ERCC1, ABCB1 and MTHFR genes and alterations in their mRNA expression can affect the in vitro chemosensitivity to cisplatin and gemcitabine. Materials & methods: Polymorphisms in these genes were evaluated by direct sequencing. mRNA expression levels were assessed by realtime PCR. In vitro chemosensitivity to cisplatin and gemcitabine was expressed as IC50 values, using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay. Results: There was a significant, positive correlation between RRM1 mRNA expression and IC50 values for gemcitabine (r = 0.6533, p = 0.0045), and there was a significant, negative correlation between ABCB1 mRNA expression and IC50 values for cisplatin (r = -0.5459, p = 0.0287). When examining the association between the polymorphisms and IC50, we found that only the MTHFR 1298A>C polymorphism showed a tendency to be more chemosensitiv...
Funding Information
  • International Science & Technology Cooperation Program (2013DFA31610)
  • the Program for Changjiang Scholars and Innovative Research Team (IRT1230)
  • the National Natural Science Foundation (NO.81372784, NO.81101646)
  • The Natural Science Foundation in Heilongjiang Province (QC08C90)
  • The New Century Support Program
  • Ministry of Education (NCET-10-0149, NCET-11-0954)

This publication has 58 references indexed in Scilit: